William Cenac, MD
Sports Medicine · New Iberia, LANPI 1629175633
Payments from drug & device makers
What this record shows
Stryker accounts for 74.3% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $1,904 and has fallen 85.9% since, to $269 in 2025. That places this record below the midpoint for sports medicine clinicians in LA, where the typical reported total is $3,045.
Across 68 payments — averaging $40.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Pacira Pharmaceuticals Incorporated$127
- Johnson & Johnson$89
- Bioventus LLC$80
- Kowa Pharmaceuticals America, Inc.$73
- Pacira Therapeutics, Inc.$66
- plus $269 from 10 others
What the payments were for
- Travel & lodging$1,22245%
- Food & beverage$1,52155%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 26 | $2,039 |
| Pacira Pharmaceuticals Incorporated | 7 | $127 |
| Johnson & Johnson | 5 | $89 |
| Bioventus LLC | 5 | $80 |
| Kowa Pharmaceuticals America, Inc. | 5 | $73 |
| Pacira Therapeutics, Inc. | 3 | $66 |
| Mimedx Group, Inc. | 3 | $62 |
| Amgen | 4 | $46 |
| Pfizer | 2 | $34 |
| Zyla Life Sciences, Inc. | 2 | $27 |
| Vericel Corporation | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Dynasplint Systems Inc. | 1 | $11 |
| Biodelivery Sciences International, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,418
How this compares
$2,743 in reported general payments places this provider in the 45th percentile of 82 sports medicine providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tolmetin Sodium | 51 | $123,865 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,810 | $31,867 |
| Orphenadrine-Aspirin-CaffeineOrphenadrine/Aspirin/Caffeine | 39 | $30,204 |
| EliquisApixaban | 23 | $12,644 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 444 | $11,622 |
| Tizanidine Hcl | 429 | $2,345 |
| Meloxicam | 834 | $2,045 |
| Celecoxib | 143 | $1,953 |
| Tramadol Hcl | 183 | $1,645 |
| Diclofenac Sodium-MisoprostolDiclofenac Sodium/Misoprostol | 14 | $1,638 |
| Gabapentin | 147 | $1,415 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 40 | $1,168 |
| Fentanyl | 12 | $1,129 |
| Cyclobenzaprine Hcl | 94 | $821 |
| Pregabalin | 33 | $717 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $34 | $12,64423 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 82 sports medicine providers in Louisiana.
Other sports medicine in New Iberia
- Felix SavoieNew Orleans$1.4M
- Misty SuriNew Orleans$1.2M
- Michael ObrienNew Orleans$391K
- Brett CascioLake Charles$82K
- Brian GodshawNew Orleans$69K
- Andrew GottschalkJefferson$45K
- Michael LeddyAlexandria$44K
- Steven JonesHammond$38K
- Mario Lobao GoncalvesShreveport$32K
- Jeremy BurnhamBaton Rouge$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.